Skip to McMaster Navigation Skip to Site Navigation Skip to main content

Orthopedic surgery patients do fine without opioid painkillers

Patients can recover from orthopedic surgery just as well without using opioid-based painkillers, according to a McMaster University and Hamilton Health Sciences (HHS) study.

By Fram Dinshaw October 12, 2022

A headshot of Olufemi Ayeni. He is wearing a blue shirt and smiling at the camera.
Olufemi Ayeni, a professor of surgery at McMaster and an orthopedic surgeon at Hamilton Health Sciences (HHS), is the corresponding author on a study that found patents can recover from orthopedic surgery just as well without using opioid-based painkillers. (Photo courtesy Hamilton Health Sciences)

Expert Featured In This Story

Olufemi Ayeni
Olufemi Ayeni

Professor

See Profile

Patients can recover from orthopedic surgery just as well without using opioid-based painkillers, says a McMaster University and Hamilton Health Sciences (HHS) study published by the Journal of the American Medical Association (JAMA).

Study results showed that by prescribing a combination of three non-opioid painkillers to patients, researchers successfully reduced approximately tenfold the amounts of opioids consumed over a six-week post-operative period, without altering their pain levels.

Corresponding author Olufemi Ayeni and his team gleaned their results by enrolling 193 patients between March 2021 and March 2022 from three Hamilton hospitals including HHS’ McMaster University Medical Centre and Hamilton General Hospital and St. Joseph’s Healthcare Hamilton.

The patients were randomly assigned to either a control group of 98 receiving standard opioid-based painkillers or an opioid-free group (93) receiving a combination therapy of naproxen, acetaminophen and pantoprazole and a patient educational infographic. The opioid-free group did have access to opioid medication if required for pain. Each patient undergoing outpatient knee or shoulder arthroscopic surgery was monitored for six weeks after their operation.

After the six weeks, those in the control group had had an average of 72.6 mg of opioids, compared to 8.4 mg in the opioid-sparing group. Six patients in the control group and two patients in the opioid-sparing group asked for opioid medication after discharge. Difference in pain scores, patient satisfaction with care and number of adverse events were not significantly different.

Co-investigators with Ayeni were orthopedic surgeon Nolan Horner and orthopedic surgery residents Seper Ekhtiari and Aaron Gazendam.

“This study clearly shows that many of these surgical patients can be treated safely without opioid medications in a select population,” said Ayeni, professor of surgery at McMaster and an orthopedic surgeon at HHS.

“Furthermore, by reducing the number of opioids prescribed, we can collectively reduce the development of a reservoir of unused medications that can cause harm to many in society,” he said.

“By one estimate, there are at least 100,000 of these surgeries in Canada annually, meaning that shifting prescription practices to reduce opioid use can reduce patient exposure and, by extension, the potential for dependency on opioids.”

By comparison, Ayeni said more than one million orthopedic surgeries were performed annually in the United States from 2006 to 2016.

Opioids remain the post-operative painkiller of choice for orthopedic specialists on both sides of the border, but North America’s ongoing opioid epidemic is forcing a rethink among clinicians, Ayeni said, adding that orthopedic specialists at times prescribe more opioids than recommended by medical guidelines.

Ayeni said that by switching to non-opioid painkillers after surgery, surgeons can play their part in combatting the ongoing opioid epidemic and reduce the risk of dependency in patients recovering from orthopedic surgery.

Funding for the study was received from Physician Services Incorporated and the Hamilton Health Sciences New Investigator Fund.

Three researchers standing side-by-side in a university laboratory.

McMaster scientists develop tech to reproduce rare medicinal molecules 

The novel technology efficiently produces lab-created copies of some of nature’s most sought-after molecules, a discovery that could accelerate broad drug development efforts.
Young woman in pain sitting on sofa, clutching pillow to tummy.

Analysis: A new saliva test for endometriosis is in trials. What this and other new endo tests mean for you

Could new tests shorten the long road to an endometriosis diagnosis? The promise is compelling, but the evidence is not there yet, write experts Mathew Leonardi and Narges Kalani.
A city shrouded in hazy smog.

Analysis: Vulnerability to wildfire smoke is in our genes, thanks to an evolutionary quirk

Mutations that occurred tens of thousands of years ago made humans uniquely sensitive to particulate air pollution, writes expert Dawn Bowdish.